Jacob Eifer Møller
Jacob Eifer Møller says: “In Denmark, almost 10.000 individuals annually suffer from a heart attack. In 5-10% of the patients, the damage to the heart is so extensive that the heart will not pump enough blood to meet the body’s requirement for oxygen and shock will develop. This condition is called cardiogenic shock. It seems intuitive beneficial to place a device that can pump blood to failing organs when the heart cannot. However, this treatment called mechanical circulatory support (MCS) is costly and associated with risk of serious complications, and evidence to guide choice of treatment is poor. The main objectives of this study are to improve the understanding of the use and consequence of advanced MCS, to improve patient selection for MCS and to assess the most beneficial way to apply this hyperinvasive treatment. This will be pursued through translational research, retrospective data studies with individual validation of data, and through a randomized clinical study.”
Jacob Eifer Møller is Professor at Department of Cardiology Odense University Hospital and University of Southern Denmark and Consultant at the Heart Center, Cardiac Intensive Care Unit, Rigshospitalet.